Recent studies have highlighted the role of various prostanoid receptors in modulating inflammatory pathways, suggesting that dysregulation of PTGER1 could contribute to the tumor microenvironment's inflammatory state, potentially exacerbating cancer progression [10]. The gene discussed is PTGER1; the disease is neoplasm.